Alzheimer’s Association International Conference 2016 (AAIC) – July 27, 2016

Anavex-1-1666x833.png

Event: Poster presentation: Safety and Efficacy 31 Week Data of ANAVEX 2-73 in a Phase 2a Study in Mild-Moderate Alzheimer’s Disease Patients


Date/Time:Wednesday, July 27, 2016; 1:00 p.m. to 2:00 p.m. EDT


Location: Hall D/E, Metro Toronto Convention Centre, Toronto, ON

1/0